Clinical Review| Volume 53, ISSUE 5, P653-661, November 2017

Controversies in Corticosteroid use for Sepsis

Published:September 12, 2017DOI:



      Severe sepsis and septic shock are potentially deadly conditions managed in the emergency department (ED). Management centers on source control, fluid resuscitation, broad-spectrum antimicrobials, and vasopressors as needed. The use of corticosteroids is controversial.


      To evaluate the evidence behind corticosteroid therapy in patients with septic shock.


      Septic shock is associated with severe mortality and morbidity. Cytokine release produces a systemic inflammatory state. Vasopressor-resistant septic shock warrants consideration of the disease state and other pathologies such as adrenal insufficiency. Many studies and meta-analyses have been conducted evaluating corticosteroid therapy for this population. High-dose corticosteroid therapy is associated with increased harm, but physiologic-dose corticosteroids may decrease the need for vasopressors. Mortality benefit is controversial, with much of the literature demonstrating no effect. The risk of superinfection is not suggested by the majority of studies. The Surviving Sepsis Campaign advises consideration of corticosteroids in patients with vasopressor and fluid-resistant septic shock. Patients with vasopressor-resistant septic shock with no contraindications to corticosteroids may benefit from hydrocortisone 100 mg intravenously (i.v.) every 8 h or 50 mg i.v. every 6 h. Fludrocortisone is not recommended at this time.


      Septic shock is associated with higher mortality, specifically for patients with vasopressor and fluid-refractory shock. The use of physiologic-dose steroids can reduce vasopressor requirements and improve time of shock resolution. Current literature suggests corticosteroids do not improve mortality, but further studies are required.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. hospitals, 2009. Agency for Healthcare Research and Quality, Rockville, MD. Available at: Accessed May 5, 2016.

        • Rhodes A.
        • Evans L.E.
        • Alhazzani W.
        • et al.
        Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock: 2016.
        Crit Care Med. 2017; 45: 486-552
        • Russell J.A.
        Management of sepsis.
        N Engl J Med. 2006; 355: 699-713
        • Dombrovskiy V.Y.
        • Martin A.A.
        • Sunderram J.
        • Paz H.L.
        Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.
        Crit Care Med. 2007; 35: 1244-1250
        • Rivers E.
        • Nguyen B.
        • Havstad S.
        • et al.
        Early goal-directed therapy in the treatment of severe sepsis and septic shock.
        N Engl J Med. 2001; 345: 1368-1377
        • Yealy D.M.
        • Kellum J.A.
        • et al.
        • ProCESS Investigators
        A randomized trial of protocol-based care for early septic shock.
        N Engl J Med. 2014; 370: 1683-1693
        • Peake S.L.
        • et al.
        • ARISE Investigators
        • Anzics Clinical Trials Group
        Goal-directed resuscitation for patients with early septic shock.
        N Engl J Med. 2014; 371: 1496-1506
        • Mouncey P.R.
        • Osborn T.M.
        • Power G.S.
        • et al.
        Trial of early, goal-directed resuscitation for septic shock.
        N Engl J Med. 2015; 372: 1301-1311
        • Nguyen H.B.
        • Jaehne A.K.
        • Jayaprakash N.
        • et al.
        Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.
        Crit Care. 2016; 20: 160
        • Remick D.G.
        Pathophysiology of sepsis.
        Am J Pathol. 2007; 170: 1435-1444
        • Annane D.
        • Bellissant E.
        • Bollaert P.E.
        • et al.
        Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.
        JAMA. 2009; 301: 2362-2375
        • Minneci P.C.
        • Deans K.J.
        • Eichacker P.Q.
        • Natanson C.
        The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis.
        Clin Microbiol Infect. 2009; 15: 308-318
        • Minneci P.C.
        • Deans K.J.
        • Natanson C.
        Corticosteroid therapy for severe sepsis and septic shock.
        JAMA. 2009; 302 (author reply 1644): 1643
        • Sligl W.I.
        • Milner Jr., D.A.
        • Sundar S.
        • et al.
        Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis.
        Clin Infect Dis. 2009; 49: 93-101
        • Annane D.
        • Bellissant E.
        • Bollaert P.E.
        • Briegel J.
        • Keh D.
        • Kupfer Y.
        Corticosteroids for treating sepsis.
        Cochrane Database Syst Rev. 2015; : CD002243
        • Lamberts S.W.
        • Bruining H.A.
        • de Jong F.H.
        Corticosteroid therapy in severe illness.
        N Engl J Med. 1997; 337: 1285-1292
        • Cooper M.S.
        • Stewart P.M.
        Corticosteroid insufficiency in acutely ill patients.
        N Engl J Med. 2003; 348: 727-734
        • Newsome H.H.
        • Rose J.C.
        The response of human adrenocorticotrophic hormone and growth hormone to surgical stress.
        J Clin Endocrinol Metab. 1971; 33: 481-487
        • Hume D.M.
        • Bell C.C.
        • Bartter F.
        Direct measurement of adrenal secretion during operative trauma and convalescence.
        Surgery. 1962; 52: 174-187
        • Boonen E.
        • Vervenne H.
        • Meersseman P.
        • et al.
        Reduced cortisol metabolism during critical illness.
        N Engl J Med. 2013; 368: 1477-1488
        • Vadas P.
        • Pruzanski W.
        Plasma cortisol levels in patients with septic shock.
        Crit Care Med. 1991; 19: 300-301
        • Beishuizen A.
        • Thijs L.G.
        • Vermes I.
        Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma.
        Intensive Care Med. 2001; 27: 1584-1591
        • Hammond G.L.
        • Smith C.L.
        • Paterson N.A.
        • Sibbald W.J.
        A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils.
        J Clin Endocrinol Metab. 1990; 71: 34-39
        • Mesotten D.
        • Vanhorebeek I.
        • Van den Berghe G.
        The altered adrenal axis and treatment with glucocorticoids during critical illness.
        Nat Clin Pract Endocrinol Metab. 2008; 4: 496-505
        • Marik P.E.
        • Pastores S.M.
        • Annane D.
        • et al.
        Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.
        Crit Care Med. 2008; 36: 1937-1949
        • Balk R.A.
        Steroids for septic shock: back from the dead? (Pro).
        Chest. 2003; 123: 490S-499S
        • McGee S.
        • Hirschmann J.
        Use of corticosteroids in treating infectious diseases.
        Arch Intern Med. 2008; 168: 1034-1046
        • Schumer W.
        Steroids in the treatment of clinical septic shock.
        Ann Surg. 1976; 184: 333-341
        • Shine K.I.
        • Kuhn M.
        • Young L.S.
        • Tillisch J.H.
        Aspects of the management of shock.
        Ann Intern Med. 1980; 93: 723-734
        • Spink W.W.
        ACTH and adrenocorticosteroids as therapeutic adjuncts in infectious diseases.
        N Engl J Med. 1957; 257: 1031-1035
        • Wagner Jr., H.N.
        • Bennett Jr., I.L.
        • Lasagna L.
        • et al.
        The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin.
        Bull Johns Hopkins Hosp. 1956; 98: 197-215
        • Kass E.H.
        Adrenocorticosteroids and the management of infectious diseases.
        AMA Arch Intern Med. 1958; 102: 1-4
        • Bennett Jr., I.L.
        • Finland M.
        • Hamburger M.
        The effectiveness of hydrocortisone in the management of severe infections.
        JAMA. 1963; 183: 462
        • Bone R.C.
        • Fisher Jr., C.J.
        • Clemmer T.P.
        • Slotman G.J.
        • Metz C.A.
        • Balk R.A.
        A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
        N Engl J Med. 1987; 317: 653-658
        • Veterans Administration Systemic Sepsis Cooperative Study Group
        Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.
        N Engl J Med. 1987; 317: 659-665
        • Sprung C.L.
        • Caralis P.V.
        • Marcial E.H.
        • et al.
        The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study.
        N Engl J Med. 1984; 311: 1137-1143
        • Cronin L.
        • Cook D.J.
        • Carlet J.
        • et al.
        Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.
        Crit Care Med. 1995; 23: 1430-1439
        • Sessler C.N.
        Steroids for septic shock: back from the dead? (Con).
        Chest. 2003; 123: 482S-489S
        • Carlet J.
        From mega to more reasonable doses of corticosteroids: a decade to recreate hope.
        Crit Care Med. 1999; 27: 672-674
        • Bollaert P.E.
        • Charpentier C.
        • Levy B.
        • Debouverie M.
        • Audibert G.
        • Larcan A.
        Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
        Crit Care Med. 1998; 26: 645-650
        • Briegel J.
        • Forst H.
        • Haller M.
        • et al.
        Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
        Crit Care Med. 1999; 27: 723-732
        • Yildiz O.
        • Doganay M.
        • Aygen B.
        • Guven M.
        • Kelestimur S.
        • Tutuu A.
        Physiological-dose steroid therapy in sepsis.
        Crit Care. 2002; 6: 251-258
        • Annane D.
        • Sebille V.
        • Charpentier C.
        • et al.
        Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock.
        JAMA. 2002; 288: 862-871
        • Oppert M.
        • Schindler R.
        • Husung C.
        • et al.
        Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
        Crit Care Med. 2005; 33: 2457-2464
        • Moran J.L.
        • Graham P.L.
        • Rockliff S.
        • Bersten A.D.
        Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.
        Crit Care. 2010; 14: R134
        • Minneci P.C.
        • Deans K.J.
        • Banks S.M.
        • Eichacker P.Q.
        • Natanson C.
        Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose.
        Ann Intern Med. 2004; 141: 47-56
        • Keh D.
        • Sprung C.L.
        Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review.
        Crit Care Med. 2004; 32: S527-S533
        • Sprung C.L.
        • Annane D.
        • Keh D.
        • et al.
        Hydrocortisone therapy for patients with septic shock.
        N Engl J Med. 2008; 358: 111-124
        • Wang C.
        • Sun J.
        • Zheng J.
        • et al.
        Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials.
        Anesth Analg. 2014; 118: 346-357
        • Sherwin R.L.
        • Garcia A.J.
        • Bilkovski R.
        Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine.
        J Emerg Med. 2012; 43: 7-12
        • Gibbison B.
        • Lopez-Lopez J.A.
        • Higgins J.P.
        • et al.
        Corticosteroids in septic shock: a systematic review and network meta-analysis.
        Crit Care. 2017; 21: 78
        • Patel G.P.
        • Balk R.A.
        Systemic steroids in severe sepsis and septic shock.
        Am J Respir Crit Care Med. 2012; 185: 133-139
        • Stanbury R.
        • Graham E.
        Systemic corticosteroid therapy—side effects and their management.
        Br J Ophthalmol. 1998; 82: 704-708
        • Melby J.C.
        • Spink W.W.
        Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection.
        J Clin Invest. 1958; 37: 1791-1798
        • Bouachour G.
        • Roy P.M.
        • Guiraud M.P.
        The repetitive short corticotropin stimulation test in patients with septic shock.
        Ann Intern Med. 1995; 123: 962-963
        • Sibbald W.J.
        • Short A.
        • Cohen M.P.
        • Wilson R.F.
        Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections.
        Ann Surg. 1977; 186: 29-33
        • Schein R.M.
        • Sprung C.L.
        • Marcial E.
        • et al.
        Plasma cortisol levels in patients with septic shock.
        Crit Care Med. 1990; 18: 259-263
        • Hamrahian A.H.
        • Oseni T.S.
        • Arafah B.M.
        Measurements of serum free cortisol in critically ill patients.
        N Engl J Med. 2004; 350: 1629-1638
        • Moran J.L.
        • Chapman M.J.
        • O'Fathartaigh M.S.
        • et al.
        Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock.
        Intensive Care Med. 1994; 20: 489-494
        • Rothwell P.M.
        • Udwadia Z.F.
        • Lawler P.G.
        Cortisol response to corticotropin and survival in septic shock.
        Lancet. 1991; 337: 582-583
        • Marik P.E.
        • Zaloga G.P.
        Adrenal insufficiency during septic shock.
        Crit Care Med. 2003; 31: 141-145
        • Siraux V.
        • De Backer D.
        • Yalavatti G.
        • et al.
        Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests.
        Crit Care Med. 2005; 33: 2479-2486
        • Venkatesh B.
        • Mortimer R.H.
        • Couchman B.
        • Hall J.
        Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study.
        Anaesth Intensive Care. 2005; 33: 201-209
        • Loisa P.
        • Uusaro A.
        • Ruokonen E.
        A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock.
        Anesth Analg. 2005; 101: 1792-1798
        • Briegel J.
        • Sprung C.L.
        • Annane D.
        • et al.
        Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock.
        Intensive Care Med. 2009; 35: 2151-2156
        • The COIITSS Study Investigators
        Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
        JAMA. 2010; 303: 341-348
        • Venkatesh B.
        • Myburgh J.
        • Finfer S.
        • et al.
        The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
        Crit Care Resusc. 2013; 15: 83-88
        • Keh D.
        • Trips E.
        • Marx G.
        • et al.
        • for the SepNet–Critical Care Trials Group
        Effect of hydrocortisone on development of shock among patients with severe sepsis. The HYPRESS Randomized Clinical Trial.
        JAMA. 2016; 316: 1775-1785

      Linked Article

      • Erratum
        Journal of Emergency MedicineVol. 54Issue 5
        • Preview
          Long B, Koyfman A. Controversies in Corticosteroid Use for Sepsis. J Emerg Med. 2017;53(5):653–61.
        • Full-Text
        • PDF